Lactate/lactylation in ocular development and diseases
In a commentary on the investment, Gilead chief executive Daniel O'Day said that the company already carries out most of its R&D within the US and has "been increasing our investment in US manufacturing over the last several years, with two large-scale cell therapy sites, and we have additional investment projects underway that are expected to run through 2028." Around $4 billion of the new tranche of funding is earmarked for capital projects, including labs and equipment, with another $5 billion aimed at "technology, operations, and R&D site activities." The remaining $2 billion will be spent on "digital and advanced engineering activities." Gilead expects to create around 800 new jobs from the new funding allocation, with another 2,200 in indirect positions like construction, by 2028
3.4.2 Natural products and botanical-derived therapies Natural products are emerging as alternatives to conventional medications
News Release February 28, 2015 Use of Magnesium and Probiotics Rise, Multivitamins and Weight Loss Supplements Fall, According to ConsumerLab.com Survey White Plains, New York, February 28, 2015 A recent survey of over 10,000 people who use dietary supplements shows the most popular dietary supplement to be fish oil, followed by multivitamins, CoQ10, vitamin D, B vitamins, magnesium, calcium, probiotics, and vitamin C
